2022 International Congress Archives - Page 90 of 153

Medication safety in Parkinson’s disease patients: evaluation of recommendations for decision support in the national drug-disease interaction database

JJ. de Jong, CCM. Stuijt, MME. Diesveld, T. van Laar, SD. Borgsteede (Groningen, Netherlands)
Melatonin attenuates the bidirectional Gut-Brain axis mediated inflammation caused by Ambient Particulate Matter (PM2.5) and averts neurodegeneration

SAM. Panda, VGM. Naidu (Guwahati, India)
Merging global cohorts of manifesting and non-manifesting carriers of pathogenic variants in known Parkinson’s disease genes

K. Roopnarain, E. Vollstedt,, L. Lange, S. Padmanabhan, C. Blauwendraat, A. Singleton, K. Katja, C. Klein (Luebeck, Germany)
Meta-analysis between LARGE-PD cohorts reveals new potential susceptibility regions on the chromosome X

T. Peixoto Leal, S. Rao, M. Inca-Martinez, M. Gouveia, J. French-Kwawu, V. Borda, E. Mason, D. Loesch, A. Horimoto, E. Sarihan, M. Cornejo-Olivas, L. Torres, P. Mazzetti, C. Cosentino, E. Sarapura-Castro, A. Rivera-Valdivia, A. Medina, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H. Ferraz, C. Rieder, A. Schumacher-Schuh, B. Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, S. Moreno, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C. Arboleda-Bustos, D. Yearout, C. Zabetian, T. Thornton, T. O'Connor, I. Mata (Cleveland, USA)
Meta-optimization to select stimulation settings for deep brain stimulation in Parkinson’s disease

M. Connolly, F. Isbaine, J. Willie, R. Gross, A. Devergnas, S. Miocinovic (Atlanta, USA)
Metabolic Biomarkers of Parkinson’s Disease in Peripheral Tissue

L. Mischley, E. Shankland, S. Liu, S. Bhayana, D. Marcinek (Seattle, USA)
Metabolic profile in the brain with Fragile X-associated Tremor/Ataxia Syndrome (FXTAS)

M. Salcedo-Arellano, M. Johnson, Y. Hwang, Y. Mclennan, E. Mcbride, P. Juarez, B. Durbin-Johnson, F. Tassone, R. Hagerman, V. Martinez-Cerdeno (Sacramento, USA)
Metagenomic exploration of the gut microbiome in a sibling-controlled pilot study of children with Tourette Syndrome

L. Sycuro, O. Coker, H. Ramay, K. Muirhead, T. Pringsheim, R. Cortez, D. Martino (Calgary, Canada)
Methods of biochemical diagnosis early stage of Parkinson’s disaese in Uzbekistan

B. Kurbanov (Tashkent, Uzbekistan)
mGlu3 receptors in Parkinson’s disease as a candidate target for neuroprotective therapy: evidence from preclinical studies to human genetic.

M. Alborghetti, L. Di Menna, V. Bruno, G. Battaglia, FE. Pontieri, E. Bianchini, M. Simmaco, M. Borro, F. Nicoletti (Rome, Italy)